Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Long-term safety Research status : Limited long-term human studies (newer peptides) Available data : Animal studies show excellent safety Human case reports very positive No known serious adverse effects Mitochondrial support theoretically beneficial Precautionary approach : Start with lower doses Monitor how you feel Consider periodic breaks Track health markers Contraindications Avoid if : Pregnancy or breastfeeding (no safety data) Active cancer (theoretical mitochondrial support to cancer cells) Severe cardiovascular disease (consult doctor) Consult doctor if : Chronic health conditions Taking multiple medications Mitochondrial disorders (ironically, may need medical supervision) Monitoring Recommended blood work : Baseline metabolic panel Glucose/HbA1c (if using for metabolic health) Liver/kidney function Retest at 12 weeks Frequency : Every 3-6 months during long-term use Biomarkers to track : Fasting glucose Insulin sensitivity markers Inflammatory markers (hs-CRP) Energy levels (subjective) Sourcing quality NAD+ peptides Quality critical for effectiveness and safety
3 Issue 1, 09 February 2020
View BPC-157 This provider offers competitive starting prices and a simplified sign-up process
Krause Analytical, a family-owned laboratory that Finnrick hires for much of its testing, also works with the F.D.A
Yes, you can repeat PRP therapy
For those wanting to do everything possible, hyperbaric chambers and red light therapies have some limited evidence, with red light therapies often being more accessible to consumers
